Blog

T cells

Preparing for Cell and Gene Therapy 3.0

Patient data is mission-critical data — especially in cell and gene therapy.

In cell and gene therapy (CGT), the patient is the process is the product. Patient and/or donor data is an essential part of manufacturing and delivery, in unique and complex ways. It is also fundamental to patient safety and product and process knowledge, providing the opportunity to reduce risk and accelerate development.

Read More
March 9, 2020

Q&A: five questions for Phil Calvin

Today, Vineti is thrilled to announce that Phil Calvin has joined Vineti as our Chief Technology Officer. A veteran technology executive at...

March 3, 2020

Quality Management Systems for advanced therapies, Part 3: a risk based approach – what does this mean for advanced therapies?

Note: this post is the third in a five-part series on Quality Management Systems (including cGMP and Quality Risk Management)...

March 2, 2020

Continuing operations safely during coronavirus

At our core, Vineti is a technology company focused on health, well-being, and patient safety. Our software platform manages critical...

February 25, 2020

Quality Management Systems for advanced therapies, Part 1: the essentials

Note: this post is the first in a five-part series on Quality Management Systems (including cGMP and Quality Risk Management)...

February 25, 2020

Quality Management Systems for advanced therapies, Part 2: six areas of focus

Note: this post is the second in a five-part series on Quality Management Systems (including cGMP and Quality Risk Management)...

February 21, 2020

Data management for advanced therapies, Part 8: the benefits of a strategic approach

Note: this post is the eighth in an eight-part series on data management strategies for personalized therapeutics, such as cell...

February 19, 2020

Data management for advanced therapies, Part 7: summing up the strategies

Note: this post is the seventh in an eight-part series on data management strategies for personalized therapeutics, such as cell...

February 12, 2020

Data management for advanced therapies, Part 6: efficiencies across the supply chain

Note: this post is the sixth in an eight-part series on data management strategies for personalized therapies, such as cell...

February 11, 2020

Data management for advanced therapies, Part 5: traceability

Note: this post is the fifth in an eight-part series on data management strategies for personalized therapies, such as cell...

February 5, 2020

Our Series C and the road ahead

Today, we announced Vineti’s $35 million Series C round of investment. A first-of-its-kind investor coalition of industry leaders — Cardinal Health,...

January 30, 2020

Data management for advanced therapies, Part 4: working with multiple stakeholders

Note: this post is the fourth in an eight-part series on data management strategies for personalized therapies, such as cell...

January 15, 2020

Vineti Announces New Board of Directors Member

SAN FRANCISCO, January 15, 2020 — Vineti, Inc., the provider of the leading digital platform of record for personalized therapeutics,...